$370.48−0.49%Close 13 Nov 2026 · Market value $30.10B
Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.
Valuation
Labcorp is valued at $30.10B on its latest close. Its price is 30.0 times its earnings.
| Market value | $30.10B |
|---|
| Enterprise value | $36.53B |
|---|
| Price / earnings | 29.98 |
|---|
| Price / sales | 2.06 |
|---|
| Price / book | 3.40 |
|---|
| EV / EBITDA | 16.53 |
|---|
| EV / sales | 2.50 |
|---|
| Price / free cash flow | 23.39 |
|---|
| Price / free cash flow, own 5-year average | 16.75 |
|---|
| EV / EBIT | 24.33 |
|---|
| EV / free cash flow | 28.40 |
|---|
| Free cash flow yield | 4.3% |
|---|
| Dividend yield | 0.8% |
|---|
Share price
| Latest close | $370.48 |
|---|
| Day's change | −0.5% |
|---|
| 52-week high | $375.10 |
|---|
| 52-week low | $245.00 |
|---|
| From 52-week high | −1.2% |
|---|
| Return · 1 month | +16.5% |
|---|
| Return · 3 months | +11.3% |
|---|
| Return · year to date | +47.7% |
|---|
| Return · 1 year | +39.3% |
|---|
| Beta · 1 year against the S&P 500 | 0.36 |
|---|
| 50-day average | $329.64 |
|---|
| 200-day average | $292.41 |
|---|
| RSI 14 | 69.5 |
|---|
| Average volume · 20 sessions | 783K |
|---|
Margins and returns
For fiscal 2025, as filed.
| Gross margin | 28.8% |
|---|
| Operating margin | 9.9% |
|---|
| Net margin | 6.3% |
|---|
| Free cash flow margin | 8.6% |
|---|
| Return on equity | 10.5% |
|---|
| Return on assets | 5.9% |
|---|
| Return on invested capital | 7.0% |
|---|
| Return on invested capital, 5-year average | 7.5% |
|---|
| Return on capital employed | 9.0% |
|---|
| Stock-based compensation / revenue | 0.9% |
|---|
Financial position
At the end of fiscal 2025.
| Cash and equivalents | $532.3M |
|---|
| Total debt | $6.46B |
|---|
| Net debt | $5.93B |
|---|
| Current ratio | 1.42 |
|---|
| Quick ratio | 0.95 |
|---|
| Debt / equity | 0.75 |
|---|
| Net debt / EBITDA | 2.87 |
|---|
| Interest coverage | 6.18 |
|---|
Growth
| Revenue, latest quarter on a year | +6.9% |
|---|
| Revenue, twelve months on a year | +6.0% |
|---|
| EPS, latest quarter on a year | +3.2% |
|---|
| EPS, twelve months on a year | +19.6% |
|---|
| Revenue, 5-year compound | −0.0% |
|---|
| Revenue, 10-year compound | +4.9% |
|---|
| Net income, 5-year compound | −10.8% |
|---|
| Free cash flow, 5-year compound | −7.2% |
|---|
| EPS, 5-year compound | −8.0% |
|---|
Shares and dividends
For fiscal 2025, as filed.
| Diluted shares | 83.8M |
|---|
| Shares outstanding, 5-year compound | −3.1% |
|---|
| Net share repurchases | $447.5M |
|---|
| Dividends per share | $2.88 |
|---|
| Dividend payout | 27.5% |
|---|
Taxes
For fiscal 2025, as filed.
| Income tax expense | $229.8M |
|---|
LH in the terminal
Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.